RDD Online, organizers of the Respiratory Drug Delivery (RDD) meetings has announced that a virtual conference called simply RDD 2021 will replace RDD Europe 2021, which had been scheduled to take place May 4-7 in Antibes, France. The 2021 conference is the second RDD meeting to switch to a virtual format due to the COVID-19 pandemic; Digital RDD 2020 was scheduled on … [Read more...] about RDD 2021 goes virtual, replacing RDD Europe 2021
News
Berry launches RS01X connected DPI
Berry Global has announced the launch of the RS01X connected dry powder inhaler, a new version of its RS01 single dose DPI that integrates with Amiko's Respiro inhaler monitoring platform. The RS01X includes an integral battery and does not require charging, the company said. The Respiro platform, which received the CE mark for use with the Spiromax, Nexthaler, and … [Read more...] about Berry launches RS01X connected DPI
AireHealth gets 510(k) clearance for connected nebulizer
According to Florida-based startup AireHealth, the company has received 510(k) clearance from the FDA for its VitalMed connected portable vibrating mesh nebulizer. Earlier this year, AireHealth acquired BreathResearch and its VitalBreath virtual respiratory health monitoring platform. In 2021, the company said, the VitalMed nebulizer will connect to a new app called … [Read more...] about AireHealth gets 510(k) clearance for connected nebulizer
Regeneron partners with Penn to study feasibility of intranasal delivery of its antibody cocktail for COVID-19
Regeneron Pharmaceuticals is collaborating with researchers at the University of Pennsylvania (Penn) to study the feasibility of intranasal delivery of Regeneron’s casirivimab and imdevimab antibody cocktail for the prevention of COVID-19, the university said. The antibody cocktail, which recently received emergency use authorization from the FDA, is currently given … [Read more...] about Regeneron partners with Penn to study feasibility of intranasal delivery of its antibody cocktail for COVID-19
Kindeva to develop inhaled cannabinoid formulations for BOL Pharma
Kindeva Drug Delivery has announced a new agreement with Israeli medical cannabis company Breath of Life International (BOL Pharma) for development of formulations of several cannabinoids for delivery via Kindeva MDIs. The formulations will initially be for the purpose of feasibility studies. BOL intends to develop the MDIs for the treatment of CND conditions … [Read more...] about Kindeva to develop inhaled cannabinoid formulations for BOL Pharma
Codagenix completes dosing in Phase 1 trial of its intranasal RSV vaccine
Codagenix announced that it has completed dosing in a Phase 1 clinical trial of its intranasal CodaVax-RSV vaccine for the prevention of respiratory syncytial virus (RSV). According to Codagenix, its SAVE (Synthetic Attenuated Virus Engineering) codon deoptimization platform, "results in genetically stable vaccine strains that can engender robust immune responses and … [Read more...] about Codagenix completes dosing in Phase 1 trial of its intranasal RSV vaccine
ARS submits MAA for Neffy epinephrine nasal spray
According to ARS Pharmaceuticals, the EMA has accepted the company's marketing authorization application for its Neffy (ARS-1) epinephrine nasal spray for the emergency treatment of anaphylaxis. ARS recently announced that Recordati had acquired marketing rights to ARS-1 in the EU, Iceland, Liechtenstein, Norway, Switzerland, the UK, Russia/CIS, Turkey, the Middle … [Read more...] about ARS submits MAA for Neffy epinephrine nasal spray
Kinaset to develop Vectura inhaled pan-JAK inhibitor for the treatment of asthma
US-based startup Kinaset Therapeutics has signed a licensing and develop an inhaled pan-JAK inhibitor that was in Vectura's pipeline prior to that company's transformation into an inhalation CDMO. In July 2019, Vectura announced that it intended to find partners for development of its inhaled drug candidates. The pan-Jak inhibitor, called VR588 by Vectura and now … [Read more...] about Kinaset to develop Vectura inhaled pan-JAK inhibitor for the treatment of asthma
Dr. Reddy’s acquires several mometasone nasal sprays from Glenmark
Dr. Reddy’s Laboratories said that it has acquired several mometasone and mometasone/azelastine nasal sprays for the treatment of seasonal and perennial allergic rhinitis from Glenmark for Russia, Kazakhstan, Uzbekistan, and Ukraine. The brands included in the deal include Momat Rino (Russia, Kazakhstan, Uzbekistan); Momat Rino Advance (Russia), Momat A (Kazakhstan, … [Read more...] about Dr. Reddy’s acquires several mometasone nasal sprays from Glenmark
Nanoform introduces nanoforming technology for biologics
Nanoform Finland has announced the launch of new nanonization technology that is capable of creating biological nanoparticles down to 50 nm. The company said that it has filed for US patents covering the technology and currently has two non-GMP lines capable of producing biological nanoparticles for a proof of concept study. Nanoform CTO Niklas Sandler said, "We … [Read more...] about Nanoform introduces nanoforming technology for biologics